The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of trimodality therapy (TMT) with rate of local-regional relapse and rare luminal-only relapse for patients with esophageal and esophagogastric junction (E-EGJ) cancer: Implications for the surveillance strategy.
Kazuki Sudo
No relevant relationships to disclose
Takashi Taketa
No relevant relationships to disclose
Arlene M. Correa
No relevant relationships to disclose
Maria-Claudia Campagna
No relevant relationships to disclose
Roopma Wadhwa
No relevant relationships to disclose
Mariela A. Blum
No relevant relationships to disclose
Ritsuko Komaki
No relevant relationships to disclose
Jeffrey H. Lee
No relevant relationships to disclose
Manoop S. Bhutani
No relevant relationships to disclose
Brian Weston
No relevant relationships to disclose
Zhongxing X. Liao
No relevant relationships to disclose
David C. Rice
No relevant relationships to disclose
Stephen Swisher
No relevant relationships to disclose
Wayne Lewis Hofstetter
No relevant relationships to disclose
Jaffer A. Ajani
No relevant relationships to disclose